NCT06936553

Brief Summary

This study will include 51 patients diagnosed with healthy, reversible and irreversible pulpitis. IL-8, FGF-1 and VEGF levels will be compared using pulpal tissue, gingival crevicular fluid, dentinal fluid samples collected from the teeth of these patients. First, the DOS sample will be collected non-invasively using periopaper strips without local anesthesia. Then, the caries will be cleaned by applying local anesthesia and rubber dam to the patient and a dentinal fluid sample will be collected noninvasively using PVDF membranes. In teeth with pulp exposure due to caries, the pulp tissue that needs to be removed will not be disposed of but collected as a sample. Routine root canal treatment procedures will then continue and treatment of the teeth will be completed. The collected samples will be analyzed for IL-8, FGF-1 and VEGF levels by ELISA test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 12, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 3, 2025

Completed
Last Updated

December 5, 2025

Status Verified

April 1, 2025

Enrollment Period

6 months

First QC Date

April 12, 2025

Last Update Submit

November 27, 2025

Conditions

Keywords

pulpal diagnosisVEGFpulpitisFGF-1IL-8

Outcome Measures

Primary Outcomes (1)

  • IL-8, FGF-1 and VEGF expression levels in dentinal fluid, GCF and pulp tissue samples

    IL-8, FGF-1 and VEGF levels will be measured in dentinal fluid, GCF and pulp tissue samples obtained during routine root canal treatment. The analysis will be performed using ELISA. The aim is to compare expression levels between patients with healthy pulp, reversible pulpitis and irreversible pulpitis.

    Day 1

Secondary Outcomes (1)

  • Correlation analysis between IL-8, FGF-1 and VEGF levels in dentinal fluid, GCF and pulp tissue samples

    Day 1

Study Arms (3)

Healthy pulp group

Irreversible pulpitis group

Reversible pulpitis group

Eligibility Criteria

Age16 Years - 60 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsbiologically male and female patients
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study will include patients aged between 16-60 years who presented to Kırıkkale University, Faculty of Dentistry, Department of Endodontics with the indication of root canal treatment and were diagnosed with healthy pulp status (Group 1), symptomatic irreversible pulpitis (Group 2) and asymptomatic reversible pulpitis (Group 3).

You may qualify if:

  • Control group:
  • Unrestored, caries-free vital teeth with healthy pulp
  • Orthodontically indicated teeth for extraction
  • wisdom teeth indicated for extraction in terms of oral hygiene
  • teeth that require root canal treatment for prosthetic purposes
  • Reversible pulpitis group:
  • Teeth that react mildly to cold, hot, sour or sweet stimuli
  • Teeth with no history of spontaneous pain
  • Teeth that respond to cold test and electric pulp test within normal limits
  • Teeth that are not sensitive to chewing or percussion
  • Irreversible pulpitis group:
  • Teeth with a history of continuous moderate or severe spontaneous pain
  • Teeth sensitive to percussion
  • Teeth without periapical pathology

You may not qualify if:

  • Patients requiring antibiotic prophylaxis.
  • Patients with diabetes or haematological diseases.
  • Patients who have used antibiotics or anti-inflammatory drugs in the last three weeks.
  • Patients who are pregnant during treatment.
  • Patients with intense plaque and tartar on their teeth, redness and bleeding in the gums.
  • Patients with severe gingivitis, generalised periodontitis or periodontal pocket depth of more than 3 mm.
  • Patients with no response to pulp sensitivity tests, presence of sinus tract, presence of periapical pathology on radiography.
  • Teeth without pulp exposure after caries removal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırıkkale University Faculty of Dentistry

Kırıkkale, 71450, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulpitis

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor doctor

Study Record Dates

First Submitted

April 12, 2025

First Posted

April 20, 2025

Study Start

March 3, 2025

Primary Completion

September 3, 2025

Study Completion

October 3, 2025

Last Updated

December 5, 2025

Record last verified: 2025-04

Locations